Document is current
Any future updates will be listed below
-
Authors
de Wilde, Arno https://orcid.org/0000-0002-3510-5510
van Buchem, Marieke M.
Otten, René H. J.
Bouwman, Femke
Stephens, Andrew
Barkhof, Frederik
Scheltens, Philip
van der Flier, Wiesje M.
-
Funding
Funding for this research was provided by:
Stichting LSH-TKI (LSHM16025)
ZonMw (733050201)
- License Information
-
More Information
Article History
First Online: 28 July 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: FBa serves as a consultant for Biogen-Idec, Janssen Alzheimer Immunotherapy, Bayer-Schering, Merck-Serono, Roche, Novartis, Genzume, and Sanofi-aventis and has received sponsorship from EU-H2020, NOW, SMSR, TEVA, Novartis, and Toshiba, and serves on the editorial boards of Radiology, Brain, Neuroradiology, MSJ, and Neurology. PS has acquired grant support (for the institution) from GE Healthcare, Danone Research, Piramal, and MERCK. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, GE Healthcare, Novartis, Sanofi, Nutricia, Probiodrug, Biogen, Roche, Avraham, and EIP Pharma. Research programs of WMvdF have been funded by ZonMW, NWO, EU-FP7, Alzheimer Nederland, Cardiovasculair Onderzoek Nederland, stichting Dioraphte, Gieskes-Strijbis fonds, Biogen, Boehringer Ingelheim, Piramal Imaging, Roche BV, Janssen Stellar, and Combinostics. All funding is paid to her institution. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
